Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial
Patil, S. B, Tamirat, M, Khazhidinov, K, Ardizzoni, E, Atger, M, Austin, A, Baudin, E, Bekhit, M, Bektasov, S, Berikova, E, Bonnet, M, Caboclo, R, Chaudhry, M, Chavan, V, Cloez, S, Coit, J, Coutisson, S, Dakenova, Z, De Jong, B. C, Delifer, C, Demaisons, S, Do, J. M, Dos Santos Tozzi, D, Ducher, V, Ferlazzo, G, Gouillou, M, Khan, U, Kunda, M, Lachenal, N, LaHood, A. N, Lecca, L, Mazmanian, M, McIlleron, H, Moreau, M, Moschioni, M, Nahid, P, Osso, E, Oyewusi, L, Panda, S, Pâquet, A, Thuong Huu, P, Pichon, L, Rich, M. L, Rupasinghe, P, Salahuddin, N, Sanchez Garavito, E, Seung, K. J, Velásquez, G. E, Vallet, M, Varaine, F, Yuya-Septoh, F. J, Mitnick, C. D, Guglielmetti, L
Published in Current controlled trials in cardiovascular medicine (30.11.2023)
Published in Current controlled trials in cardiovascular medicine (30.11.2023)
Get full text
Journal Article